Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Page

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Frontiers in Immunology|March 25, 2022
Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody ThresholdsDiego Cantoni, Martin Mayora-Neto, Angalee Nadesalingam, et al.
Msphere|January 31, 2023
VelcroVax: a "Bolt-On" Vaccine Platform for Glycoprotein DisplayNatalie J Kingston, Keith Grehan, Joseph S Snowden, et al.
Emerging Microbes & Infections|April 30, 2026
Evaluation of candidate reference materials for the harmonization of Lassa fever serologyEmma M Bentley, Ndapewa Ithete, Jane Mitchell, et al.
Nature Biotechnology|November 3, 2022
The Coronavirus Standards Working Group's roadmap for improved population testingTim Mercer, Neil Almond, Michael A Crone, et al.
Frontiers in Immunology|December 6, 2021
Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 CasesJavier Castillo-Olivares, David A Wells, Matteo Ferrari, et al.
The Lancet. Microbe|January 26, 2024
Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysisMark Manak, Luc Gagnon, Steven Phay-Tran, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Frontiers in Immunology|March 25, 2022
Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody ThresholdsDiego Cantoni, Martin Mayora-Neto, Angalee Nadesalingam, et al.
Msphere|January 31, 2023
VelcroVax: a "Bolt-On" Vaccine Platform for Glycoprotein DisplayNatalie J Kingston, Keith Grehan, Joseph S Snowden, et al.
Emerging Microbes & Infections|April 30, 2026
Evaluation of candidate reference materials for the harmonization of Lassa fever serologyEmma M Bentley, Ndapewa Ithete, Jane Mitchell, et al.
Nature Biotechnology|November 3, 2022
The Coronavirus Standards Working Group's roadmap for improved population testingTim Mercer, Neil Almond, Michael A Crone, et al.
Frontiers in Immunology|December 6, 2021
Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 CasesJavier Castillo-Olivares, David A Wells, Matteo Ferrari, et al.
The Lancet. Microbe|January 26, 2024
Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysisMark Manak, Luc Gagnon, Steven Phay-Tran, et al.
Pageof 7